¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16
±³À°ÀÏÀÚ : 2024-06-16
±³À°Àå¼Ò : COEX, Seoul, Korea  

±³À°ÁÖÁ¦ : APCN & KSN 2024 4ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  

À̸ÞÀÏ : ksn@ksn.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡ (ÀÏ¹Ý 1Á¡ / Çʼö 2Á¡)

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 250,000¿ø  

ºñ°í ¡áȸ¿ø: »çÀü(200,000)/ÇöÀå(250,000) ¡áºñȸ¿ø: »çÀü(250,000)/ ÇöÀå(250,000) ¡áPhysician in training/Nurse/Paramedics/Allied Health: »çÀü(100,000)/ ÇöÀå(125,000) *Student, ¸¸65¼¼ ÀÌ»ó ȸ¿ø: ¸éÁ¦


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 08:30~09:00 Can HIF Stabilizers Replace ESA in Patients with Hemodialysis? Pros vs. Cons ±èÁöÀº(°í·Á´ëÇб³ ±¸·Îº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 09:00~09:30 CKD-MBD Management: About the New Phosphate Binder Ȳ¼±´ö(ÀÎÇϴ뺴¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 09:30~10:00 Strategies for Achieving High Volume HDF Á¶¾ÆÁø(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 10:30~11:00 Monitoring and Surveillance in Hemodialysis Access ±èÇü´ö(°¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 11:00~11:30 Vascular Ultrasound ±¸»ó°Ç(»ý¸í¼±ÀÇ¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 1 11:30~12:00 Application of Ultrasound in Nephrology Other than Vascular Ultrasound ±èÀºÁ¤(ÇѸ²´ëÇб³ µ¿Åº¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 08:30~09:00 Ç÷¾×Åõ¼®¸·ÀÇ ±¸Á¶¿Í ¼º´É ¹× °¡Àå ÀûÇÕÇÑ Åõ¼®¸·ÀÇ ¼±ÅÃÀº ÀÌÀåÇÑ(ºÐ´çÁ¦»ýº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 09:00~09:30 Current Evidence of Anticoagulation Therapy in Hemodialysis Patient ¹ÚÇýÀÎ(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 09:30~10:00 Ç÷¾×Åõ¼®À» À§ÇÑ ¼öÁú°ü¸® ¹× Åõ¼®Àåºñ À¯Áö¸¦ À§ÇÑ ¼Òµ¶Áöħ ±èÀ¯°æ(¹Ú½ºÅÍ)

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 10:30~11:00 Åõ¼®È¯ÀÚÀÇ °¡·Á¿òÁõ °ü¸® Á¤º¸¿µ(ÇѸ²´ëÇб³ °­³²¼º½Éº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 11:00~11:30 ÀÚµ¿º¹¸·Åõ¼®(APD)ÀÇ ÀÌÇØ¿Í °£È£ °û¹ÌÇý(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 2 11:30~12:00 Ç÷¾×Åõ¼® ÁßȯÀÚ °ü¸® ÀÌÇö¿µ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 08:30~08:50 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í °ü·ÃÇÑ À±¸®Àû ±Ç°í¾È ¼±ÀοÀ(¿¹¼öº´¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 08:50~09:10 °í·É ȯÀÚÀÇ Åõ¼® Áß´Ü°ú °ü·ÃÇÑ À±¸®Àû ±Ç°í¾È ±è¼­¸°(¾ç»êºÎ»ê´ëÇб³º´¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 09:10~09:30 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü°ú °ü·ÃÇÑ ÇØ¿Ü ±Ç°í¾È¿¡ ´ëÇÑ À±¸®Àû Á¢±Ù ¹× ºñ±³ ºÐ¼® ÃÖÀº°æ(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 09:30~10:00 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü ±Ç°í¾È¿¡ ´ëÇÑ À±¸®Àû °í·Á»çÇ× ÀÌÀº¿µ(ºÎ»ê °¡Å縯´ëÇб³) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:00~10:30 °í·É ȯÀÚÀÇ Åõ¼® À¯º¸¿Í Áß´Ü ¶§ º¸Á¸ÄáÆÏ°ü¸®ÀÇ À±¸®Àû °í·Á»çÇ× ¹× Çʿ伺 ½Å¼ºÁØ(µ¿±¹´ëÇб³ Àϻ꺴¿ø) Çʼö

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:30~10:50 ADPKD Treatment and New European Guidelines on Tolvaptan Vladimir Tesar(Charles University)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 10:50~11:10 Genetic- and Kidney Disease-related Asymptomatic Hyperuricemial Mechanisms and Clinical Implications Stephanie Steiger(LMU Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 11:10~11:30 Modeling of Genetic Kidney Disease and Development of New Therapeutics Using Patient Derived Induced Pluripotent Stem Cells Á¤º´ÇÏ(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 3 11:30~11:50 Current Treatment Status of Fabry Nephropathy in Korea ÀÌÇÏÁ¤(Harvard Medical School)

Åä·Ð 06¿ù 16ÀÏ Room 3 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 08:30~09:50 KRCP: The Current and the Future Hakmmok Kang, Kent Doi, Ming-Zhi Zhang, Çã¼±(Vanderbilt University, The University of Tokyo Graduate School of Medicine, ÇѸ²´ëÇб³)

Åä·Ð 06¿ù 16ÀÏ Room 4 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 10:30~11:00 Emergency Preparedness and Kidney Disease - Sharing Know-Hows of ISN RDPWG Ali Abu-Alfa(American University of Beirut)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 11:00~11:30 Dietary Plan for Korean Renal Hemodialysis Patients in a Disaster Emergency Situation ÀåÀ¯¹Ì(¿ï»ê´ëÇб³ ½ÄÇ°¿µ¾çÇаú)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 4 11:30~12:00 Emergency Medical System for Disaster Response in Hospitals (Centered on Artificial Kidney Units) ÃÖ¿íÁø(¿ï»ê´ëÇб³º´¿ø ÀÀ±ÞÀÇÇаú)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 08:30~08:50 Conservative Kidney Management & Palliativa Care: Dialysis Withhold and Withdrawal ½Å¼ºÁØ(µ¿±¹´ëÇб³ Àϻ꺴¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 08:50~09:10 Strategies to Increase Kidney Transplantation Mai-Szu Wu(Taipei Medical University)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 09:10~09:30 Patient Selection and Prescription of Hemodiafiltration Ikuto Masakane(Yabuki Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 09:30~09:50 PD-first Policy in Hong Kong: Pros and Cons Philip Kam-Tao Li(Prince of Wales Hospital)

Åä·Ð 06¿ù 16ÀÏ Room 5 09:50~10:00 Q&A All Speaker()

ÈÞ½Ä 06¿ù 16ÀÏ 10:00~10:30 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 10:30~10:50 HD VA Endovascular Thrombectomy, Tips for Beginners ³ª±â·®(Ãæ³²´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 10:50~11:10 Ultrasound of Kidneys and Bladder: Clinical Case Scenarios Vandana Niyyar(Emory University School of Medicine)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 11:10~11:30 Native Fistula Should Remain the First Choice of Vascular Access for Elderlies Hideki Kawanishi(Tsuchiya General Hospital)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 5 11:30~11:50 Examination of Vascular Access: Best Practices and Tools Jernej Pajek(University Medical Center Ljubljana)

Åä·Ð 06¿ù 16ÀÏ Room 5 11:50~12:00 Q&A All Speaker()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 09:00~09:30 Differences Between OPO Structures and Roles and Their Advantages and Disadvantages: (US vs Spain vs Australia) Stefan Tullius(Harvard Medical School)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 09:30~10:00 Key Foundations for OPO Success I: Ethics, Compliance, Data Integrity, and Healthcare Collaboration Ghazali Ahmad(National Heart Institute)

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 10:00~10:30 Key Foundations for OPO Success II: Comprehensive Training for Coordinators Dong Van He(Vietnam National Coordinating Center for Human Organ Transplantation (VNHOT))

ÈÞ½Ä 06¿ù 16ÀÏ 10:30~11:00 Break ()

±³À°½Ã°£ 06¿ù 16ÀÏ Room 6 11:00~11:30 Key Foundations for OPO Success III: Cultural Awareness and Public Engagement Yingyos Avihingsanon(Chulalongkorn University)

Åä·Ð 06¿ù 16ÀÏ Room 6 11:30~12:00 Panel Discussion: Country Experience Cons and Pros in OPO All Speaker()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦16ȸ ±¹¸³¾Ï¼¾ÅÍ ±¹Á¦½ÉÆ÷Áö¾ö : 2024-06-19
´ÙÀ½±Û [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-06-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 28 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 27 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 35 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 29 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 20 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 8 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 16 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 6 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 20 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 12 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 13 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷